CAN
NVCR icon

Cetera Advisor Networks’s NovoCure NVCR Stock Holding History

Cetera Advisor Networks’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,210
Closed -$268K – 2010
2021
Q2 		$268K Buy
+1,210
New +$235K ﹤0.01% 1580
2021
Q1 		– Sell
-1,308
Closed -$226K – 1523
2020
Q4 		$226K Buy
+1,308
New +$179K 0.01% 1193
2020
Q3 		– Sell
-455
Closed -$27K – 2424
2020
Q2 		$27K Buy
+455
New +$29.9K ﹤0.01% 2242

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Advisor Networks's NVCR Position: Q3 2021 in Review

Cetera Advisor Networks sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 1,210 shares — an estimated $268K sold.

Cetera Advisor Networks first reported a position in NVCR in Q2 2020 and held it in 3 quarters. The position peaked at $268K in Q2 2021. 317 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

  • Cetera Advisor Networks reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
  • Cetera Advisor Networks sold 1,210 NovoCure shares in Q3 2021, an estimated $268K.
  • Cetera Advisor Networks first reported a position in NovoCure in Q2 2020 and held it in 3 quarters.
  • Cetera Advisor Networks's NovoCure position peaked at $268K in Q2 2021.
  • 317 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Cetera Advisor Networks's 13F filing for Q3 2021, filed 16 Nov 2021.